AMENDMENT 1 TO THE COLLABORATION AND OPTION AGREEMENTCollaboration and Option Agreement • October 25th, 2012 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT 1 TO THE COLLABORATION AND OPTION AGREEMENT (the “Amendment”) is made and entered into on August 1st, 2012 (the “Amendment Date”), by and between OncoMed Pharmaceuticals, Inc., a Delaware corporation located at 800 Chesapeake Drive, Redwood City, California 94063, United States of America (“OncoMed”), and Bayer Pharma AG, a German corporation located at Müllerstrasse 178, 13353 Berlin, Germany which previously acted under the name Bayer Schering Pharma AG (“BSP”). OncoMed and BSP are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ContractMulti-Product License Agreement • October 25th, 2012 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
COLLABORATION AGREEMENT between LONZA SALES AG and ONCOMED PHARMACEUTICALS, INC.Collaboration Agreement • October 25th, 2012 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
